Japan Intellectual Property Rights: MUSCLE ATROPHY INHIBITORY COMPOSITION

Japan, Feb. 27 -- KOBE UNIV has got intellectual property rights for 'MUSCLE ATROPHY INHIBITORY COMPOSITION.' Other related details are as follows:

Application Number: JP,2021-067896

Category (FI): A61K31/7088,A61K39/395@D,A61K45/00,A61P21/00,A61P43/00,111,C07K16/18,C12Q1/68

Stage: PROBLEM TO BE SOLVED: To provide a muscle atrophy inhibitory composition.SOLUTION: A muscle atrophy inhibitory composition includes a CXCL10 expression inhibitor as an active ingredient. The muscle atrophy inhibitory composition includes, as an active ingredient, preferably a CXCL10 inhibitor, more preferably a CXCL10 neutralizing antibody, or still more preferably a TRPV2 activator. The muscle atrophy is muscle atrophy of skeletal muscle. There is also provided a screening method for an active ingredient for inhibiting muscle atrophy, using a decrease in the expression level of CXCL10 gene as an index.SELECTED DRAWING: None (Grant)

Filing Date: April 13, 2021

Publication Date: Oct. 25, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Syndication.